Pacific Biosciences of California SG&A Expense (Quarterly) Analysis

Pacific Biosciences of California Inc (PACB)

1.43 +0.05 (+3.62%) USD | NASDAQ | Apr 26, 09:52

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2009. Upgrade now.

Date	Value
December 31, 2023	46.00M
September 30, 2023	43.43M
June 30, 2023	40.57M
March 31, 2023	39.82M
December 31, 2022	45.00M
September 30, 2022	36.80M
June 30, 2022	39.25M
March 31, 2022	39.80M
December 31, 2021	37.32M
September 30, 2021	31.61M
June 30, 2021	29.06M
March 31, 2021	26.14M
December 31, 2020	17.95M
September 30, 2020	14.77M
June 30, 2020	15.13M
March 31, 2020	24.95M
December 31, 2019	16.58M
September 30, 2019	20.07M
June 30, 2019	19.08M
March 31, 2019	19.77M
December 31, 2018	20.11M
September 30, 2018	13.51M
June 30, 2018	14.94M
March 31, 2018	14.93M
December 31, 2017	14.40M

Date	Value
September 30, 2017	13.95M
June 30, 2017	15.50M
March 31, 2017	15.26M
December 31, 2016	12.99M
September 30, 2016	11.89M
June 30, 2016	11.19M
March 31, 2016	11.71M
December 31, 2015	12.78M
September 30, 2015	10.82M
June 30, 2015	10.82M
March 31, 2015	10.77M
December 31, 2014	10.00M
September 30, 2014	9.882M
June 30, 2014	8.993M
March 31, 2014	9.15M
December 31, 2013	9.06M
September 30, 2013	10.76M
June 30, 2013	9.374M
March 31, 2013	9.554M
December 31, 2012	10.67M
September 30, 2012	10.14M
June 30, 2012	11.56M
March 31, 2012	15.28M
December 31, 2011	11.81M
September 30, 2011	12.76M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

14.77M

Minimum

Sep 2020

46.00M

Maximum

Dec 2023

30.70M

Average

31.61M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks